drugset / Trial / NCT02431624
An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to assess the adhesion of BTDS patch 40 µg/h.
Timeline
- Start
- 2015-03
- Primary completion
- 2015-05
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 20 ug | Other |
| Subject | Buprenorphine | Other / unclassified | 40 ug | Other |
Indications
No indication recorded.